TickerFacts.

Sonoma Pharmaceuticals, Inc. (SNOA): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-03-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$19.53M
Year ended 2026-03-31
$21.92M
Trailing 12 months to 2026-06-30
+13.7%
3-year compound annual growth
+0.9%
5-year compound annual growth
+7.6%
10-year compound annual growth
2011-03-31: $9.75M2012-03-31: $12.74M2013-03-31: $15.45M2014-03-31: $13.67M2015-03-31: $13.85M2016-03-31: $9.37M2017-03-31: $12.82M2018-03-31: $16.66M2019-03-31: $18.97M2020-03-31: $17.93M2021-03-31: $18.63M2022-03-31: $12.63M2023-03-31: $13.27M2024-03-31: $12.73M2025-03-31: $14.29M2026-03-31: $19.53M$19.53M
2011-03-31 Revenue (USD) 2026-03-31
Period endedRevenueChange YoYSource filing
2026-03-31$19.53M+36.7%2026-06-16, From 2025-04-01
2025-03-31$14.29M+12.2%2026-06-16, From 2024-04-01
2024-03-31$12.73M-4.0%2025-06-17, From 2023-04-01
2023-03-31$13.27M+5.1%2024-06-17, From 2022-04-01
2022-03-31$12.63M-32.2%2023-06-21, From 2021-04-01
2021-03-31$18.63M+3.9%2022-07-13, From 2020-04-01
2020-03-31$17.93M-5.5%2021-07-14, From 2019-04-01
2019-03-31$18.97M+13.9%2019-07-01, From 2018-04-01
2018-03-31$16.66M+29.9%2019-07-01, From 2017-04-01
2017-03-31$12.82M+36.9%2018-06-26, From 2016-04-01
2016-03-31$9.37Mn/c2017-06-28, From 2015-04-01
2015-03-31$13.85M+1.4%2016-06-21, From 2014-04-01
2014-03-31$13.67M-11.5%2015-06-16, From 2013-04-01
2013-03-31$15.45M+21.2%2014-06-30, From 2012-04-01
2012-03-31$12.74M+30.7%2013-06-25, From 2011-04-01
2011-03-31$9.75Mn/a2012-06-21, From 2010-04-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$19.53M+36.7%
Spectral AI, Inc. (MDAI)2025-12-31$19.65M-33.6%
Nephros Inc (NEPH)2025-12-31$18.79M+32.7%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$17.44M+16.0%
DarioHealth Corp. (DRIO)2025-12-31$22.36M-17.3%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$22.54M-39.2%
Profound Medical Corp. (PROF)2025-12-31$16.10M+50.7%
Biotricity Inc. (BTCY)2026-03-31$16.00M+16.0%
Allurion Technologies, Inc. (ALUR)2025-12-31$15.23M-52.6%

Compare SNOA, MDAI, NEPH, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗